| Literature DB >> 33861753 |
Elaine Cristina de Oliveira1, Vagner Fonseca2,3,4, Joilson Xavier2, Talita Adelino5, Ingra Morales Claro6, Allison Fabri7, Eduardo Marques Macario8, Ana Elisa Viniski1, Claudio Luis Campos Souza1, Evanil Sebastiana Gomes da Costa9, Claudia Soares de Sousa9, Flávia Guimarães Dias Duarte9, Arnaldo Correia de Medeiros8, Carlos F Campelo de Albuquerque10, Rivaldo Venancio Cunha11, Noely Fabiana Oliveira De Moura12, Ana Maria Bispo de Filippis7, Tulio de Oliveira3, José Lourenço13, André Luiz de Abreu4, Luiz Carlos Junior Alcantara2,7, Marta Giovanetti2,7.
Abstract
Since introduction into Brazil in 2014, chikungunya virus (CHIKV) has presented sustained transmission, although much is unknown about its circulation in the midwestern states. Here, we analyze 24 novel partial and near complete CHIKV genomes from Cuiaba, an urban metropolis located in the Brazilian midwestern state of Mato Grosso (MT). Nanopore technology was used for sequencing CHIKV complete genomes. Phylogenetic and epidemiological approaches were used to explore the recent spatio-temporal evolution and spread of the CHIKV-ECSA genotype in Midwest Brazil as well as in the Americas. Epidemiological data revealed a reduction in the number of reported cases over 2018-2020, likely as a consequence of a gradual accumulation of herd-immunity. Phylogeographic reconstructions revealed that at least two independent introductions of the ECSA lineage occurred in MT from a dispersion event originating in the northeastern region and suggest that the midwestern Brazilian region appears to have acted as a source of virus transmission towards Paraguay, a bordering South American country. Our results show a complex dynamic of transmission between epidemic seasons and suggest a possible role of Brazil as a source for international dispersion of the CHIKV-ECSA genotype to other countries in the Americas.Entities:
Mesh:
Year: 2021 PMID: 33861753 PMCID: PMC8051810 DOI: 10.1371/journal.pntd.0009290
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Epidemiological data for the sequenced samples.
| ID | Sample type | Date onset symptoms | Collection date | Age | Sex | State | Municipality | Ct value | Reads | Coverage (%) | Acession Number |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CB08 | Serum | 2018-02-23 | 2018-02-23 | 33 | F | MT | Cuiaba | 18,59 | 900 | 43,70 | MN428504 |
| CB04 | Serum | 2018-05-18 | 2018-05-21 | 22 | F | MT | Cuiaba | 30,98 | 4318 | 52,60 | MN428505 |
| CB09 | Serum | 2018-01-29 | 2018-02-01 | 23 | F | MT | Cuiaba | 19,66 | 291904 | 93,60 | MN428506 |
| CB10 | Serum | 2018-07-03 | 2018-07-05 | 29 | F | MT | Cuiaba | 26,88 | 620828 | 82,70 | MN428507 |
| CB12 | Serum | 2018-04-25 | 2018-04-27 | 22 | F | MT | Cuiaba | 30,65 | 175360 | 78,60 | MN428508 |
| CB17 | Serum | 2018-03-11 | 2018-03-13 | 27 | M | MT | Cuiaba | 22,16 | 99926 | 83,90 | MN428509 |
| CB18 | Serum | 2018-04-24 | 2018-04-25 | 43 | M | MT | Cuiaba | 27,38 | 554552 | 79,90 | MN428510 |
| CB16 | Serum | 2018-04-12 | 2018-04-18 | 31 | F | MT | Cuiaba | 19,87 | 577642 | 85,10 | MN428511 |
| CB22 | Serum | 2018-03-10 | 2018-03-13 | 26 | M | MT | Cuiaba | 28,33 | 147381 | 88,50 | MN428512 |
| CB19 | Serum | 2018-04-05 | 2018-04-26 | 37 | F | MT | Cuiaba | 24,93 | 514308 | 82,70 | MN428513 |
| CB23 | Serum | 2018-03-13 | 2018-03-13 | 30 | F | MT | Cuiaba | 23,62 | 278973 | 53,00 | MN428514 |
| CB24 | Serum | 2018-03-18 | 2018-03-20 | 62 | F | MT | Cuiaba | 20,31 | 235010 | 93,50 | MN428515 |
| CB26 | Serum | 2018-03-21 | 2018-03-23 | 22 | F | MT | Cuiaba | 24,08 | 4167 | 86,50 | MN428516 |
| CB27 | Serum | 2018-03-15 | 2018-03-17 | 40 | F | MT | Cuiaba | 29,33 | 6855 | 84,10 | MN428517 |
| CB28 | Serum | 2018-03-07 | 2018-03-08 | 19 | F | MT | Cuiaba | 20,07 | 4391 | 89,40 | MN428518 |
| CB29 | Serum | 2018-03-15 | 2018-03-16 | 20 | F | MT | Cuiaba | 20,96 | 6384 | 88,20 | MN428519 |
| CB31 | Serum | 2018-03-08 | 2018-03-09 | 31 | F | MT | Cuiaba | 29,22 | 7537 | 85,20 | MN428520 |
| CB32 | Serum | 2018-03-16 | 2018-03-16 | 29 | F | MT | Cuiaba | 21,22 | 6010 | 87,10 | MN428521 |
| CB30 | Serum | 2018-03-07 | 2018-03-08 | 24 | F | MT | Cuiaba | 31,21 | 9104 | 83,50 | MN428522 |
| CB33 | Serum | 2018-03-08 | 2018-03-08 | 31 | F | MT | Cuiaba | 22,16 | 4753 | 89,40 | MN428523 |
| CB34 | Serum | 2018-03-05 | 2018-03-06 | 34 | F | MT | Cuiaba | 22,25 | 6554 | 86,50 | MN428524 |
| CB35 | Serum | 2018-03-05 | 2018-03-06 | 24 | F | MT | Cuiaba | 25,24 | 4454 | 89,40 | MN428525 |
| CB36 | Serum | 2018-03-06 | 2018-03-06 | 16 | F | MT | Cuiaba | 21,42 | 8795 | 86,40 | MN428526 |
| CB37 | Serum | 2018-03-05 | 2018-03-06 | 23 | F | MT | Cuiaba | 26,95 | 3957 | 89,40 | MN428527 |
Ct = RT-qPCR quantification cycle threshold value.